Oncocyte Corp Stock Technical Analysis
| OCX Stock | USD 2.46 0.05 1.99% |
As of the 25th of April, OncoCyte Corp holds the Risk Adjusted Performance of (0.07), variance of 10.25, and Coefficient Of Variation of (769.99). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OncoCyte Corp, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down thirteen technical drivers for OncoCyte Corp, which can be compared to its competitors. Please check OncoCyte Corp mean deviation and maximum drawdown to decide if OncoCyte Corp is priced some-what accurately, providing market reflects its current price of 2.46 per share. Please also confirm OncoCyte Corp jensen alpha, which is currently at (0.42) to check out the company can sustain itself at a future point.
OncoCyte Corp Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as OncoCyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OncoCyteOncoCyte |
OncoCyte Corp Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 4.19 | Buy | 5 | Odds |
Most OncoCyte analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand OncoCyte stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of OncoCyte Corp, talking to its executives and customers, or listening to OncoCyte conference calls.
OncoCyte Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
OncoCyte Corp Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of OncoCyte Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.
OncoCyte Corp Trend Analysis
Use this graph to draw trend lines for OncoCyte Corp. You can use it to identify possible trend reversals for OncoCyte Corp as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual OncoCyte Corp price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.OncoCyte Corp Best Fit Change Line
The following chart estimates an ordinary least squares regression model for OncoCyte Corp applied against its price change over selected period. The best fit line has a slop of 0.0052 , which may imply that the returns on investment in OncoCyte Corp will continue to fail. It has 122 observation points and a regression sum of squares at 1.02, which is the sum of squared deviations for the predicted OncoCyte Corp price change compared to its average price change.About OncoCyte Corp Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of OncoCyte Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of OncoCyte Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on OncoCyte Corp price pattern first instead of the macroeconomic environment surrounding OncoCyte Corp. By analyzing OncoCyte Corp's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of OncoCyte Corp's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to OncoCyte Corp specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Dividend Yield | 0.027 | 0.0243 | 0.0255 | Price To Sales Ratio | 24.97 | 16.8 | 15.96 |
OncoCyte Corp April 25, 2024 Technical Indicators
Most technical analysis of OncoCyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for OncoCyte from various momentum indicators to cycle indicators. When you analyze OncoCyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 3.85 | |||
| Mean Deviation | 2.19 | |||
| Coefficient Of Variation | (769.99) | |||
| Standard Deviation | 3.2 | |||
| Variance | 10.25 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | 3.84 | |||
| Maximum Drawdown | 15.77 | |||
| Value At Risk | (6.23) | |||
| Potential Upside | 4.53 | |||
| Skewness | (0.19) | |||
| Kurtosis | 1.65 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.Note that the OncoCyte Corp information on this page should be used as a complementary analysis to other OncoCyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for OncoCyte Stock analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is OncoCyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OncoCyte Corp. If investors know OncoCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OncoCyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.37) | Revenue Per Share 0.196 | Quarterly Revenue Growth 0.146 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of OncoCyte Corp is measured differently than its book value, which is the value of OncoCyte that is recorded on the company's balance sheet. Investors also form their own opinion of OncoCyte Corp's value that differs from its market value or its book value, called intrinsic value, which is OncoCyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OncoCyte Corp's market value can be influenced by many factors that don't directly affect OncoCyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OncoCyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if OncoCyte Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OncoCyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.